Cited by 366Health Systems, Economic Evaluations, Quality of LifeMeta-analysis and systematic reviewsDelphi Technique in Research

The DOI matches its Crossref record; 74 of the 76 references it cites were found in a registry or an index.

Examining the Value and Quality of Health Economic Analyses: Implications of Utilizing the QHES

Open access

Ofman, Joshua J., Sullivan, Sean D., Neumann, Peter J., Chiou, Chiun-Fang, Henning, James M., Wade, Sally W., Hay, Joel W.·2003·Journal of Managed Care Pharmacy

DOI 10.18553/jmcp.2003.9.1.53PMC PMC10437166

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVE: To examine the increasing use of health economic studies and practical implications of evaluating their quality utilizing the Quality of Health Economic Studies (QHES) instrument. METHODS: We first reviewed secondary references to examine ways in which health economic analyses are used in different health care settings, the manner in which these data are appraised and evaluated, and their relevance and value in decision making. The QHES, a new instrument designed to support fast, accurate initial assessments of study quality, was then introduced and validated. A case study was performed using the QHES to score the quality of 30 cost-effectiveness studies in gastroesophageal reflux disease (GERD) published since 1985. Areas where additional research could guide efforts to identify and enhance the use of higher-quality cost-effectiveness studies were suggested. RESULTS: Results from the published validation study of the QHES demonstrated the validity of this new instrument. The resulting QHES scores in the case study of GERD papers ranged from 43 to 91 with a mean of 63.6 (SD=14.7). Approximately 27% of the studies rated had scores less than 50, and 27% had scores above or equal to 75. All 30 studies made conclusions and recommendations and justified them based on their study results. Most studies used appropriate cost and health outcome measures. Very few studies stated the perspective of their analysis and reasons for its selection. The majority of the studies did not perform incremental analysis. CONCLUSION: An examination of the QHES validation study and the case study in GERD suggests that there is a rationale and potential utility to use a quality scoring system for cost-effectiveness studies. The QHES may play an important role in discriminating higher-quality cost-effectiveness information to enhance decision making. The QHES can also serve as a guideline for conducting and reporting future cost-effectiveness studies, as an aid in the editorial process, and for stratification in systematic reviews. Complex decisions regarding resource allocation rarely rely solely on economic considerations but do increasingly use health economic analyses. To the extent that such analyses are used, the QHES may help ensure that higher-quality analyses receive more analytic attention and greater weight in the decision-making process.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.18553/jmcp.2003.9.1.53

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
Moher, D., Pham, B., Jones, A., Cook, D. J., Jadad, A. R., Moher, M., Tugwell, P., & Klassen, T. P. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01085-x · Cited by 3,560
Users' Guides to the Medical Literature
Guyatt, G. H. (1993) · JAMA · doi:10.1001/jama.270.17.2096 · Cited by 3,083
Recommendations of the Panel on Cost-Effectiveness in Health and Medicine
Weinstein, M. C. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540150055031 · Cited by 2,455 · cited 1×
“Weinstein et al., 1996.”
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
Jüni, P. (1999) · JAMA · doi:10.1001/jama.282.11.1054 · Cited by 1,981
Guidelines for authors and peer reviewers of economic submissions to the BMJ
Drummond, M. F., & Jefferson, T. O. (1996) · BMJ · doi:10.1136/bmj.313.7052.275 · Cited by 1,827
Assessing the quality of randomized controlled trials: An annotated bibliography of scales and checklists
Moher, D., Jadad, A. R., Nichol, G., Penman, M., Tugwell, P., & Walsh, S. (1995) · Controlled Clinical Trials · doi:10.1016/0197-2456(94)00031-w · Cited by 1,308
The Role of Cost-effectiveness Analysis in Health and Medicine
Russell, L. B. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540140060028 · Cited by 1,167
Are Guidelines Following Guidelines?
Shaneyfelt, T. M., Mayo‐Smith, M. F., & Rothwangl, J. (1999) · JAMA · doi:10.1001/jama.281.20.1900 · Cited by 853
Cost-effectiveness analysis.
Robinson, R. (1993) · BMJ · doi:10.1136/bmj.307.6907.793 · Cited by 819

Show all 76 references

Research works printed but not linked: 19

Shaneyfelt TM, Mayo-Smith MF, Rothwangl J. Are guidelines following guide- lines? The methodological quality of clinical practice guidelines in the peer- reviewed medical literature. JAMA. 1999;281:1900-05.
Drummond MF, Richardson WS, O'Brien BJ, et al. User' s guide to the medical literature. XIII. How to use an article on economic analysis of clinical practice. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA. 1997; 277:1552-57.
O'Brien B, Heyland D, Richardson WS, et al. User' s guide to the medical litera- ture. XIII. How to use an article on economic analysis of clinical practice. B. What are the results and will they help me in caring for my patients? JAMA.1997; 277:1802-06.
Sonnenberg A, Inadomi JM, Becker LA. Economic analysis of step-wise treat- ment of gastroesophageal reflux disease. Aliment Pharmacol Ther. 1999;13:1003-13.
Stalhammar NO. Assessing the cost-effectiveness of medical treatments in Examining the Value and Quality of Health Economic Analyses: Implications of Utilizing the QHES acid-related diseases. The Markov chain approach applied to a comparison between intermittent and maintenance treatment of reflux esophagitis. Scand J Gastroenterol Suppl. 1993;199:8-13.
Bate C, Richardson P. Cost-effectiveness of omeprazole in the management of gastroesophageal reflux disease in clinical practice. Br J Med Econ. 1994;7:81-97.
Bate C, Hungin A, Wilcock C. Cost-effective management of gastroesophageal reflux disease in general practice. Br J Med Econ. 1993;6:81-90.
Bate C, Green J, Taylor M. Cost-effective prophylaxis against the recurrence of benign oesophageal stricture. Br J Med Econ. 1995;8:97-107.
Bate C, Richardson P. A one-year model for the cost-effectiveness of treating reflux oesophagitis. Br J Med Econ. 1992;2:5-11.
Bate C. Cost-effectiveness of omeprazole in the treatment of reflux oesophagi- tis. Br J Med Econ. 1991;1:53-61.
Bate C, Richardson P. Symptomatic assessment and cost effectiveness of treat- ments for reflux oesophagitis: comparisons of omeprazole and histamine H2- receptor antagonists. Br J Med Econ. 1992;2:37-48.
Green J, Bate C, Copeman M. A comparison of the cost-effectiveness of omeprazole and ranitidine in reflux oesophagitis. Br J Med Econ. 1995;8:37-48.
Jonsson B, Stalhammar NO. The cost-effectiveness of omeprazole and raniti- dine in intermittent and maintenance treatment of reflux oesophagitis-the case of Sweden. Br J Med Econ. 1993;6:111-26.
Phillips C, Moore A. Trial and error-an expensive luxury: economic analysis of effectiveness of proton pump inhibitors and histamine antagonists in treating reflux disease. Br J Med Econ. 1997;11:55-63.
Bate C, Richardson P. Cost-effectiveness of 20 mg and 40 mg of omeprazole in oesophageal reflux disease. Br J Med Econ. 1993;6:59-66.
Torrance GW, Blaker D, Detsky A, et al. Canadian guidelines for economic evaluation of pharmaceuticals. Canadian Collaborative Workshop for Pharmacoeconomics. Pharmacoeconomics. 1996;9:535-59.
Economic analysis of health care technology. A report on principles. Task Force on Principles for Economic Analysis of Health Care Technology. Ann Intern Med. 1995;123:61-70.
Drummond M, O'Brien B, Stoddart G, Torrance GW. Critical Assessment of Economic Evaluation. Methods for the Economic Evaluation of Health Care Programmes. Oxford, England: Oxford Medical Publications; 1997:27-51.
Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ. 1996;313:275-83.

Sorted by citations

ACC/AHA Statement on Cost/Value Methodology in Clinical Practice Guidelines and Performance Measures
Anderson, J. L., Heidenreich, P. A., Barnett, P. G., Creager, M. A., Fonarow, G. C., Gibbons, R. J., Halperin, J. L., Hlatky, M. A., Jacobs, A. K., Mark, D. B., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000042 · Cited by 521
ACC/AHA Statement on Cost/Value Methodology in Clinical Practice Guidelines and Performance Measures
Anderson, J. L., Heidenreich, P. A., Barnett, P. G., Creager, M. A., Fonarow, G. C., Gibbons, R. J., Halperin, J. L., Hlatky, M. A., Jacobs, A. K., Mark, D. B., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.016 · Cited by 447
Quality of primary care by advanced practice nurses: a systematic review
Swan, M., Ferguson, S., Chang, A., Larson, E., & Smaldone, A. M. (2015) · International Journal for Quality in Health Care · doi:10.1093/intqhc/mzv054 · Cited by 339
Health economics in the field of osteoarthritis: An Expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)
Hiligsmann, M., Cooper, C. C., Arden, N., Boers, M., Branco, J., Brandi, M. L., Bruyère, O., Guillemin, F., Hochberg, M. C., Hunter, D. J., et al. (2013) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2013.07.003 · Cited by 341
The costs and benefits of biochar production and use: A systematic review
Campion, L., Bekchanova, M., Malina, R. M., & Kuppens, T. E. (2023) · Journal of Cleaner Production · doi:10.1016/j.jclepro.2023.137138 · Cited by 301
Cost-effectiveness evidence of mental health prevention and promotion interventions: A systematic review of economic evaluations
Le, L. K., Esturas, A. C., Mihalopoulos, C., Chiotelis, O., Bucholc, J., Chatterton, M. L., & Engel, L. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003606 · Cited by 301
Cost-effectiveness of nurse practitioners in primary and specialised ambulatory care: systematic review
Martin-Misener, R., Harbman, P., Donald, F., Reid, K., Kilpatrick, K., Carter, N., Bryant-Lukosius, D., Kaasalainen, S., Marshall, D. A., Charbonneau-Smith, R., et al. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-007167 · Cited by 252
Cost-Effectiveness of Hypertension Therapy According to 2014 Guidelines
Moran, A. E., Odden, M. C., Thanataveerat, A., Tzong, K. Y., Rasmussen, P. W., Guzman, D., Williams, L. W., Bibbins-Domingo, K. B., Coxson, P. G., & Goldman, L. (2015) · New England Journal of Medicine · doi:10.1056/nejmsa1406751 · Cited by 244
Evidence and Value: Impact on DEcisionMaking – the EVIDEM framework and potential applications
Goetghebeur, M. M., Wagner, M., Khoury, H., Levitt, R. J., Erickson, L. J., & Rindress, D. (2008) · BMC Health Services Research · doi:10.1186/1472-6963-8-270 · Cited by 232
Current Evidence for Continuous Vital Signs Monitoring by Wearable Wireless Devices in Hospitalized Adults: Systematic Review
Leenen, J. P. L., Leerentveld, C., van Dijk, J. D., van Westreenen, H. L., Schoonhoven, L., & Patijn, G. A. (2020) · Journal of Medical Internet Research · doi:10.2196/18636 · Cited by 231
Economic Evaluations of Clinical Pharmacy Services: 2006–2010
Touchette, D. R., Doloresco, F., Suda, K. J., Pérez, A., Turner, S. J., Jalundhwala, Y. J., Tangonan, M. C., & Hoffman, J. M. (2014) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1414 · Cited by 235
ASHP Guidelines on the Pharmacy and Therapeutics Committee and the Formulary System
Tyler, L. S., Cole, S. W., May, J. R., Millares, M., Valentino, M. A., Vermeulen, L. C., & Wilson, A. L. (2008) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080086 · Cited by 208
Does a home-based strength and balance programme in people aged ≥80 years provide the best value for money to prevent falls? A systematic review of economic evaluations of falls prevention interventions
Davis, J. C., Robertson, M. C., Ashe, M. C., Liu-Ambrose, T., Khan, K. M., & Marra, C. A. (2010) · British Journal of Sports Medicine · doi:10.1136/bjsm.2008.060988 · Cited by 198
Cost Effectiveness of Pharmacogenetic Testing for Drugs with Clinical Pharmacogenetics Implementation Consortium ( CPIC ) Guidelines: A Systematic Review
Morris, S., Alsaidi, A. T., Verbyla, A., Cruz, A., Macfarlane, C., Bauer, J. E., & Patel, J. N. (2022) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2754 · Cited by 184
Cost-effectiveness of surgical interventions for the management of osteoarthritis: a systematic review of the literature
Kamaruzaman, H. F., Kinghorn, P., & Oppong, R. (2017) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-017-1540-2 · Cited by 182
Use of health economic evaluation in the implementation and improvement science fields—a systematic literature review
Roberts, S. L. E., Healey, A., & Sevdalis, N. (2019) · Implementation Science · doi:10.1186/s13012-019-0901-7 · Cited by 161
Growth and Quality of the Cost–Utility Literature, 1976–2001
Neumann, P. J., Greenberg, D., Olchanski, N., Stone, P. W., & Rosen, A. B. (2005) · Value in Health · doi:10.1111/j.1524-4733.2005.04010.x · Cited by 161
Self-citation
The clinical effectiveness and cost‐effectiveness of clinical nurse specialist‐led hospital to home transitional care: a systematic review
Bryant‐Lukosius, D., Carter, N., Reid, K. J., Donald, F., Martin‐Misener, R., Kilpatrick, K., Harbman, P., Kaasalainen, S., Marshall, D. A., Charbonneau-Smith, R., et al. (2015) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12401 · Cited by 152
Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA
Kristensen, F. B., Husereau, D., Huić, M., Drummond, M., Berger, M. L., Bond, K., Augustovski, F., Booth, A., Bridges, J. F. P., Grimshaw, J., et al. (2018) · Value in Health · doi:10.1016/j.jval.2018.08.010 · Cited by 134
Current Status of Cost Utility Analyses in Total Joint Arthroplasty: A Systematic Review
Nwachukwu, B. U., Bozic, K. J., Schairer, W. W., Bernstein, J. L., Jevsevar, D. S., Marx, R. G., & Padgett, D. E. (2014) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-014-3964-4 · Cited by 115
Cost Effectiveness of Pharmacogenomics
Wong, W. B., Carlson, J. J., Thariani, R., & Veenstra, D. L. (2010) · PharmacoEconomics · doi:10.2165/11537410-000000000-00000 · Cited by 108
Health Outcomes and Costs of Social Work Services: A Systematic Review
Steketee, G. S., Ross, A. M., & Wachman, M. K. (2017) · American Journal of Public Health · doi:10.2105/ajph.2017.304004 · Cited by 109
The effectiveness and cost‐effectiveness of clinical nurse specialists in outpatient roles: a systematic review
Kilpatrick, K., Kaasalainen, S., Donald, F., Reid, K., Carter, N., Bryant‐Lukosius, D., Martin‐Misener, R., Harbman, P., Marshall, D. A., Charbonneau‐Smith, R., et al. (2014) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12219 · Cited by 98
Multigene assays and molecular markers in breast cancer: systematic review of health economic analyses
Rouzier, R., Pronzato, P., Chereau, E., Carlson, J. J., Hunt, B., & Valentine, W. J. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2559-1 · Cited by 95
The quality of published health economic analyses in digestive diseases: A systematic review and quantitative appraisal
Spiegel, B. M. R., Targownik, L. E., Kanwal, F., DeRosa, V. P., Dulai, G. S., Gralnek, I. M., & Chiou, C. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.020 · Cited by 95
Self-citation
Future Directions for Cost-effectiveness Analyses in Health and Medicine
Neumann, P. J., Kim, D. D., Trikalinos, T. A., Sculpher, M. J., Salomon, J. A., Prosser, L. A., Owens, D. K., Meltzer, D. O., Kuntz, K. M., Krahn, M. D., et al. (2018) · Medical Decision Making · doi:10.1177/0272989x18798833 · Cited by 94
Self-citation
Cost-Effectiveness of Nonpharmacologic, Nonsurgical Interventions for Hip and/or Knee Osteoarthritis: Systematic Review
Pinto, D., Robertson, M. C., Hansen, P., & Abbott, J. H. (2012) · Value in Health · doi:10.1016/j.jval.2011.09.003 · Cited by 96
Challenges in Systematic Reviews of Economic Analyses
Pignone, M. P., Saha, S., Hoerger, T. J., Lohr, K. N., Teutsch, S. M., & Mandelblatt, J. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-12_part_2-200506211-00007 · Cited by 94
Cost-Effectiveness of Biological Asthma Treatments: A Systematic Review and Recommendations for Future Economic Evaluations
McQueen, R. B., Sheehan, D. N., Whittington, M. D., van Boven, J. F. M., & Campbell, J. D. (2018) · PharmacoEconomics · doi:10.1007/s40273-018-0658-x · Cited by 94
Costs and Cost-Effectiveness of Malaria Control Interventions: A Systematic Literature Review
Conteh, L., Shuford, K. V., Agboraw, E., Kont, M. D., Kolaczinski, J. H., & Patouillard, E. (2021) · Value in Health · doi:10.1016/j.jval.2021.01.013 · Cited by 96
Cost-Effectiveness Analyses of the 21-Gene Assay in Breast Cancer: Systematic Review and Critical Appraisal
Wang, S., Dang, W., Richman, I. B., Mougalian, S. S., Evans, S. B., & Gross, C. P. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.5941 · Cited by 88
The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report
McGhan, W. F., Al, M., Doshi, J. A., Kamae, I., Marx, S. E., & Rindress, D. (2009) · Value in Health · doi:10.1111/j.1524-4733.2009.00605.x · Cited by 86
Review of Eight Pharmacoeconomic Studies of the Value of Biologic DMARDs Adalimumab, Etanercept, and Infliximab) in the Management of Rheumatoid Arthritis
Doan, Q. V., Chiou, C., & Dubois, R. W. (2006) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2006.12.7.555 · Cited by 84
Self-citation
Cost-efficacy of Knee Cartilage Defect Treatments in the United States
Everhart, J. S., Campbell, A. B., Abouljoud, M. M., Kirven, J. C., & Flanigan, D. C. (2019) · The American Journal of Sports Medicine · doi:10.1177/0363546519834557 · Cited by 76
Economic evaluations of comprehensive geriatric assessment in surgical patients: a systematic review
Eamer, G., Saravana-Bawan, B. B., van der Westhuizen, B., Chambers, T., Ohinmaa, A. E., & Khadaroo, R. G. (2017) · Journal of Surgical Research · doi:10.1016/j.jss.2017.03.041 · Cited by 73
Cost analyses of obesity in Canada: scope, quality, and implications
Tran, B. X., Nair, A. V., Kuhle, S., Ohinmaa, A. E., & Veugelers, P. J. (2013) · Cost Effectiveness and Resource Allocation · doi:10.1186/1478-7547-11-3 · Cited by 72
Hospital to community transitional care by nurse practitioners: A systematic review of cost-effectiveness
Donald, F., Kilpatrick, K., Reid, K. J., Carter, N., Bryant‐Lukosius, D., Martin‐Misener, R., Kaasalainen, S., Harbman, P., Marshall, D. A., & DiCenso, A. (2014) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2014.07.011 · Cited by 71
Cost effectiveness analyses of total hip arthroplasty for hip osteoarthritis: A PRISMA systematic review
Agarwal, N., To, K., & Khan, W. S. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13806 · Cited by 69
The Economic Value of Enteral Medical Nutrition in the Management of Disease-Related Malnutrition: A Systematic Review
Freijer, K., Bours, M. J. L., Nuijten, M. J. C., Poley, M. J., Meijers, J. M. M., Halfens, R. J. G., & Schols, J. M. G. A. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.09.005 · Cited by 67
Timing of Decompressive Surgery in Patients With Acute Spinal Cord Injury: Systematic Review Update
Fehlings, M. G., Hachem, L. D., Tetreault, L. A., Skelly, A. C., Dettori, J. R., Brodt, E., Stabler-Morris, S., Redick, B. J., Evaniew, N., Martin, A. R., et al. (2024) · Global Spine Journal · doi:10.1177/21925682231197404 · Cited by 63
Cost Effectiveness of Treatments for Diabetic Retinopathy: A Systematic Literature Review
Maniadakis, N., & Konstantakopoulou, E. (2019) · PharmacoEconomics · doi:10.1007/s40273-019-00800-w · Cited by 63
Statistical Methods for Cost-Effectiveness Analyses That Use Data from Cluster Randomized Trials
Gomes, M., Grieve, R., Nixon, R. M., & Edmunds, W. J. (2011) · Medical Decision Making · doi:10.1177/0272989x11407341 · Cited by 64
Cost-Effectiveness Analyses in Orthopaedic Sports Medicine
Nwachukwu, B. U., Schairer, W. W., Bernstein, J. L., Dodwell, E. R., Marx, R. G., & Allen, A. A. (2014) · The American Journal of Sports Medicine · doi:10.1177/0363546514544684 · Cited by 60
A systematic review of cost-effectiveness of monoclonal antibodies for metastatic colorectal cancer
Lange, A., Prenzler, A., Frank, M. R., Kirstein, M. M., Vogel, A., & von der Schulenburg, J. G. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.08.008 · Cited by 59
A Systematic Review of the Cost Effectiveness of Herpes Zoster Vaccination
Szucs, T. D., & Pfeil, A. M. (2013) · PharmacoEconomics · doi:10.1007/s40273-012-0020-7 · Cited by 59
A Systematic Review of the Cost-Effectiveness of Nurse Practitioners and Clinical Nurse Specialists: What Is the Quality of the Evidence?
Donald, F., Kilpatrick, K., Reid, K., Carter, N., Martin-Misener, R., Bryant-Lukosius, D., Harbman, P., Kaasalainen, S., Marshall, D. A., Charbonneau-Smith, R., et al. (2014) · Nursing Research and Practice · doi:10.1155/2014/896587 · Cited by 59
Economic Outcomes of Treatment for Ureteral and Renal Stones: A Systematic Literature Review
Matlaga, B. R., Jansen, J. P., Meckley, L. M., Byrne, T. W., & Lingeman, J. E. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.04.008 · Cited by 59
Cost-effectiveness Analyses of Antihypertensive Medicines: A Systematic Review
Park, C., Wang, G., Durthaler, J. M., & Fang, J. (2017) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2017.06.020 · Cited by 59
Cell Therapy for Treatment of Intervertebral Disc Degeneration: A Systematic Review
Meisel, H.-J., Agarwal, N. P., Hsieh, P. C., Skelly, A. C., Park, J., Brodke, D. S., Wang, J. C., Yoon, S. T., & Buser, Z. (2019) · Global Spine Journal · doi:10.1177/2192568219829024 · Cited by 58
Patient-level costs in margin re-excision for breast-conserving surgery
Grant, Y., Al-Khudairi, R., John, E. S., Barschkett, M., Cunningham, D., Al-Mufti, R., Hogben, K. R., Thiruchelvam, P. T. R., Hadjiminas, D. J., Darzi, A. W., et al. (2018) · British journal of surgery · doi:10.1002/bjs.11050 · Cited by 58
Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Systematic Review of Cost-Effectiveness Models
Limone, B. L., Baker, W. L., Kluger, J., & Coleman, C. I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062183 · Cited by 57
Assessment of the Quality of Cost Analysis Literature in Physical Therapy
Peterson, L. E., Goodman, C. S., Karnes, E. K., Chen, C. J., & Schwartz, J. A. (2009) · Physical Therapy · doi:10.2522/ptj.20080326 · Cited by 53
Economic analyses of human genetics services: A systematic review
Carlson, J. J., Henrikson, N. B., Veenstra, D. L., & Ramsey, S. D. (2005) · Genetics in Medicine · doi:10.1097/01.gim.0000182467.79495.e2 · Cited by 55
Management of End-Stage Ankle Arthritis: Cost-Utility Analysis Using Direct and Indirect Costs
Nwachukwu, B. U., McLawhorn, A. S., Simon, M. S., Hamid, K. S., Demetracopoulos, C. A., Deland, J. T., & Ellis, S. J. (2015) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.n.01215 · Cited by 53
Economic evaluation of nurse practitioner and clinical nurse specialist roles: A methodological review
Lopatina, E., Donald, F., DiCenso, A., Martin‐Misener, R., Kilpatrick, K., Bryant‐Lukosius, D., Carter, N., Reid, K. J., & Marshall, D. A. (2017) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2017.04.012 · Cited by 53
Cost–benefit of infection control interventions targeting methicillin-resistant Staphylococcus aureus in hospitals: systematic review
Farbman, L., Avni, T., Rubinovitch, B., Leibovici, L., & Paul, M. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12280 · Cited by 48
The diagnostic utility and cost-effectiveness of selective nerve root blocks in patients considered for lumbar decompression surgery: a systematic review and economic model
Beynon, R. A., Hawkins, J. E., Laing, R. J. C., Higgins, N., Whiting, P. F., Jameson, C., Sterne, J. A. C., Vergara, P., & Hollingworth, W. (2013) · Health Technology Assessment · doi:10.3310/hta17190 · Cited by 50
Dosage for cost-effective exercise-based falls prevention programs for older people: A systematic review of economic evaluations
Winser, S. J., Chan, H. T. F., Ho, L., Chung, L. S., Ching, L. T., Lok, T. F., & Kannan, P. (2019) · Annals of Physical and Rehabilitation Medicine · doi:10.1016/j.rehab.2019.06.012 · Cited by 44
Cell‐free DNA noninvasive prenatal screening for aneuploidy versus conventional screening: A systematic review of economic evaluations
Nshimyumukiza, L., Menon, S., Hina, H., Rousseau, F., & Reinharz, D. (2017) · Clinical Genetics · doi:10.1111/cge.13155 · Cited by 46
ASHP Guidelines on the Pharmacy and Therapeutics Committee and the Formulary System
Ciccarello, C., Leber, M. B., Leonard, M. C., Nesbit, T. W., Petrovskis, M. G., Pherson, E. C., Pillen, H. A., Proctor, C., & Reddan, J. G. (2021) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxab080 · Cited by 45
Economic analyses of mental health and substance use interventions in the workplace: a systematic literature review and narrative synthesis
de Oliveira, C., Cho, E., Kavelaars, R., Jamieson, M., Bao, B., & Rehm, J. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30145-0 · Cited by 44
Health economics of rubella: a systematic review to assess the value of rubella vaccination
Babigumira, J. B., Morgan, I., & Levin, A. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-406 · Cited by 44
Cost-Effectiveness of Physical Therapy Only and of Usual Care for Various Health Conditions: Systematic Review
Bürge, E., Monnin, D., Berchtold, A., & Allet, L. (2016) · Physical Therapy · doi:10.2522/ptj.20140333 · Cited by 44
Do cancer biomarkers make targeted therapies cost-effective? A systematic review in metastatic colorectal cancer
Seo, M. K., & Cairns, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204496 · Cited by 44
A Systematic Review of Scope and Quality of Health Economic Evaluation Studies in Vietnam
Tran, B. X., Nong, V. M., Maher, R. M., Nguyen, P. K., & Luu, H. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103825 · Cited by 42
The cost effectiveness of palivizumab: a systematic review of the evidence
Smart, K. A., Lanctôt, K. L., & Paes, B. A. (2010) · Journal of Medical Economics · doi:10.3111/13696998.2010.499749 · Cited by 42
Cost-effectiveness analyses of breast cancer medications use in developing countries: a systematic review
Al-Ziftawi, N. H., Shafie, A. A., & Ibrahim, M. I. M. (2020) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2020.1794826 · Cited by 41
Is Mammography for Breast Cancer Screening Cost-Effective in Both Western and Asian Countries?: Results of a Systematic Review
Yoo, K., Kwon, J. A., Cho, E., Kang, M. H., Nam, J.-M., Choi, K. S., Kim, E., Choi, Y. J., & Park, E. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.7.4141 · Cited by 41
A framework for assessing Health Economic Evaluation (HEE) quality appraisal instruments
Langer, A. (2012) · BMC Health Services Research · doi:10.1186/1472-6963-12-253 · Cited by 41
The impact of ischaemic stroke on atrial fibrillation-related healthcare cost: a systematic review
Li, X., Tse, V. C., Au-Doung, P. L. W., Wong, I. C. K., & Chan, E. W. (2016) · EP Europace · doi:10.1093/europace/euw093 · Cited by 41
Cost analysis of telerehabilitation after arthroscopic subacromial decompression
Pastora‐Bernal, J., Martín‐Valero, R., & Barón-López, F. J. (2017) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x17723367 · Cited by 41
Is Minimal Access Spine Surgery More Cost-effective Than Conventional Spine Surgery?
Lubelski, D., Mihalovich, K. E., Skelly, A. C., Fehlings, M. G., Harrop, J. S., Mummaneni, P. V., Wang, M. Y., & Steinmetz, M. P. (2014) · Spine · doi:10.1097/brs.0000000000000571 · Cited by 39
Reliability of Two Instruments for Critical Assessment of Economic Evaluations
Au, F., Prahardhi, S., & Shiell, A. (2007) · Value in Health · doi:10.1111/j.1524-4733.2007.00255.x · Cited by 39
A systematic review on the cost effectiveness of pharmacogenomics in developing countries: implementation challenges
Sukri, A., Salleh, M. Z., Masimirembwa, C. M., & Teh, L. K. (2022) · The Pharmacogenomics Journal · doi:10.1038/s41397-022-00272-w · Cited by 38
A systematic review of the cost-effectiveness of targeted therapies for metastatic non-small cell lung cancer (NSCLC)
Lange, A., Prenzler, A., Frank, M., Golpon, H., Welte, T., & von der Schulenburg, J.-M. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-192 · Cited by 38
Arthroplasty for the surgical management of complex proximal humerus fractures in the elderly: a cost-utility analysis
Nwachukwu, B. U., Schairer, W. W., McCormick, F. M., Dines, D. M., Craig, E. V., & Gulotta, L. V. (2016) · Journal of Shoulder and Elbow Surgery · doi:10.1016/j.jse.2015.12.022 · Cited by 37
Belgian Methodological Guidelines for Pharmacoeconomic Evaluations: Toward Standardization of Drug Reimbursement Requests
Cleemput, I., Wilder, P. V., Huybrechts, M., & Vrijens, F. (2008) · Value in Health · doi:10.1111/j.1524-4733.2008.00469.x · Cited by 37
The state of health economic and pharmacoeconomic evaluation research in Zimbabwe: A review
Gavaza, P., Rascati, K. L., Brown, C. M., Lawson, K. A., & Mann, T. A. (2008) · Current Therapeutic Research · doi:10.1016/j.curtheres.2008.06.005 · Cited by 36
Assessing the quality of economic evaluations of clinical nurse specialists and nurse practitioners: A systematic review of cost-effectiveness
Marshall, D. A., Donald, F., Lacny, S., Reid, K. J., Bryant‐Lukosius, D., Carter, N., Charbonneau-Smith, R., Harbman, P., Kaasalainen, S., Kilpatrick, K., et al. (2015) · NursingPlus Open · doi:10.1016/j.npls.2015.07.001 · Cited by 36
The State of Health Economic Evaluation Research in Nigeria
Gavaza, P., Rascati, K. L., Oladapo, A. O., & Khoza, S. (2010) · PharmacoEconomics · doi:10.2165/11536170-000000000-00000 · Cited by 35
Systematic Review of the Cost-Effectiveness of Positron-Emission Tomography in Staging of Non–Small-Cell Lung Cancer and Management of Solitary Pulmonary Nodules
Cao, J. Q., Rodrigues, G., Louie, A. V., & Zaric, G. S. (2011) · Clinical Lung Cancer · doi:10.1016/j.cllc.2011.09.002 · Cited by 35
Cost-Effectiveness of Advanced Practice Nurses Compared to Physician-Led Care for Chronic Diseases: A Systematic Review.
Abraham, C. M., Norful, A. A., Stone, P. W., & Poghosyan, L. (2019) · PubMed · Cited by 35
Cost Analyses of Prosthetic Devices: A Systematic Review
Donnelley, C. A., Shirley, C., von Kaeppler, E. P., Hetherington, A. M., Albright, P., Morshed, S., & Shearer, D. (2021) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2021.02.010 · Cited by 34
Economic Evaluations of CYP2C19 Genotype-Guided Antiplatelet Therapy Compared to the Universal Use of Antiplatelets in Patients With Acute Coronary Syndrome: A Systematic Review
AlMukdad, S., Elewa, H. F., & Al‐Badriyeh, D. (2020) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248420902298 · Cited by 37
Cost-Effectiveness and Clinical Practice Guidelines: Have We Reached a Tipping Point?—An Overview
Garrison, L. P. (2016) · Value in Health · doi:10.1016/j.jval.2016.04.018 · Cited by 34
Economic Decision Model for First-Time Traumatic Patellar Dislocations in Adolescents
Nwachukwu, B. U., So, C., Schairer, W. W., Stein, B. E. S., Strickland, S. M., Green, D. W., & Dodwell, E. R. (2017) · The American Journal of Sports Medicine · doi:10.1177/0363546517703347 · Cited by 34
Evaluation and review of pharmacoeconomic models
Hay, J. W. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.9.1867 · Cited by 33
Self-citation
Effectiveness of National Pricing Policies for Patent-Protected Pharmaceuticals in the OECD: A Systematic Literature Review
Wettstein, D. J., & Boes, S. (2018) · Applied Health Economics and Health Policy · doi:10.1007/s40258-018-0437-z · Cited by 32
Hip protectors are cost-effective in the prevention of hip fractures in patients with high fracture risk
de Bot, R. T. A. L., Veldman, H. D., Witlox, A. M. A., van Rhijn, L. W., & Hiligsmann, M. (2020) · Osteoporosis International · doi:10.1007/s00198-019-05252-8 · Cited by 32
Economic Evaluations of Interventions to Optimize Medication Use in Older Adults with Polypharmacy and Multimorbidity: A Systematic Review
Laberge, M., Sirois, C., Lunghi, C., Gaudreault, M., Nakamura, Y., Bolduc, C., & Laroche, M. (2021) · Clinical Interventions in Aging · doi:10.2147/cia.s304074 · Cited by 32
Cost-effectiveness Evaluations Among the Direct Oral Anticoagulants for the Prevention and Treatment of Venous Thromboembolism: Systematic Review
Mukdad, M. A., Al‐Badriyeh, D., & Elewa, H. F. (2019) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029619849103 · Cited by 33
Cervical Degenerative Disease
Alvin, M. D., Qureshi, S. A., Klineberg, E. O., Riew, K. D., Fischer, D. J., Norvell, D. C., & Mroz, T. E. (2014) · Spine · doi:10.1097/brs.0000000000000547 · Cited by 31
Cost-effectiveness of minimally invasive sacroiliac joint fusion
Cher, D., Frasco, M. A., Arnold, R. J. G., & Polly, D. W. (2015) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s94266 · Cited by 31
Is it a Chimera? A systematic review of the economic evaluations of CAR-T cell therapy
Petrou, P. (2019) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2019.1651646 · Cited by 31
The State of Health Economic Research in South Africa
Gavaza, P., Rascati, K. L., Oladapo, A. O., & Khoza, S. (2012) · PharmacoEconomics · doi:10.2165/11589450-000000000-00000 · Cited by 36
The Quality of Cost-Utility Analyses in Orthopedic Trauma
Nwachukwu, B. U., Schairer, W. W., O’Dea, E. M., McCormick, F. M., & Lane, J. M. (2015) · Orthopedics · doi:10.3928/01477447-20150804-53 · Cited by 30
A systematic review of the economic evaluations of Enzyme Replacement Therapy in Lysosomal Storage Diseases
Katsigianni, E. I., & Petrou, P. (2022) · Cost Effectiveness and Resource Allocation · doi:10.1186/s12962-022-00369-w · Cited by 29
Risk of respiratory syncytial virus infection in preterm infants: reviewing the need for prevention
Abraha, H. Y., Lanctôt, K. L., & Paes, B. A. (2015) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2015.1098536 · Cited by 29
Systematic reviews of health economic evaluations: A structured analysis of characteristics and methods applied
Luhnen, M., Prediger, B., Neugebauer, E. A. M., & Mathes, T. (2019) · Research Synthesis Methods · doi:10.1002/jrsm.1342 · Cited by 29
Methodologic Quality of Cost-Effectiveness Analyses of Surgical Procedures
Kruper, L. L., Kurichi, J. E., & Sonnad, S. S. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000231802.83152.59 · Cited by 28

Authors: Ofman, J. J., Sullivan, S. D., Neumann, P. J., Chiou, C.-F., Henning, J. M., Wade, S. W., & Hay, J. W.
ORCID: Sullivan, Sean D.
Neumann, Peter J.
Hay, Joel W.
Venue: Journal of Managed Care Pharmacy
Publisher: Academy of Managed Care Pharmacy
Published: 2003-01
Volume: 9
Issue: 1
Pages: 53-61
ISSN: 1083-4087 (ISSN-L)
1944-706X
DOI: 10.18553/jmcp.2003.9.1.53
PMC: PMC10437166
OpenAlex: W2130921523
Cited by: 366
References: 76
Citations by year: 2026: 14 · 2025: 18 · 2024: 18 · 2023: 26 · 2022: 25 · 2021: 39 · 2020: 27 · 2019: 35 · 2018: 17 · 2017: 20 · 2016: 16 · 2015: 21 · 2014: 24 · 2013: 18 · 2012: 11
FWCI: 9.62
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Journal of Managed Care Pharmacy (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
Social Sciences › Sociology and Political Science › Delphi Technique in Research
Keywords: instrument validation, gastroesophageal reflux disease, healthcare decision-making, resource allocation, reporting guidelines, systematic reviews
MeSH terms: Cost-Benefit Analysis, Delivery of Health Care, Humans, United States, Economics, Pharmaceutical

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Examining the Value and Quality of Health Economic Analyses: Implications of Utilizing the QHES

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks